Bruker price target lowered to $60 from $65 at Barclays

Barclays lowered the firm’s price target on Bruker (BRKR) to $60 from $65 and keeps an Overweight rating on the shares. The firm sees elevated skepticism on the implied OMx ramp throughout the year given the Q1 guidance coming in below expectations.